← Leaderboards
Qinwen Mao
Utah State Higher Education System--University Of Utah
$669,638
Attributed
$884,940
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $436.3K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$884,940 · 2
By mechanism
R21$884,940 · 2
Top collaborators
- Hehuang Xie2 shared
Most similar at Utah State Higher Education System--University Of Utah
Same institution · by research overlap
- Daniel R Scoles$6,542,278
- Stefan M. Pulst$18,000,219
- Jesse Rowley$4,972,542
- Robin Mark Shaw$12,032,317
- Carol S Lim$5,461,677
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposNeuron LossDensityFundingMeetingsNerve DegenerationDrug DiscoveryDiagnosisFoundationsFrontotemporal Lobar DegenerationsAmyloid Beta-ProteinLinkMolecularMonoclonal AntibodiesHippocampal SclerosisBindingBiological MarkersComplexAntibodiesExclusionCytoplasmBrainDementiaNeuropathology
Grant awards (4)
Spatial Transcriptomics for Investigating the Interaction between TDP-43 Proteinopathy and Hippocampal Sclerosis in Alzheimer's Disease$188,314
R21 · FY2025 · AG · contact PI
Spatial Transcriptomics for Investigating the Interaction between TDP-43 Proteinopathy and Hippocampal Sclerosis in Alzheimer's Disease$242,290
R21 · FY2024 · AG · contact PI
A new biomarker for frontotemporal lobar degeneration with TDP-43 proteinopathy and Alzheimer's disease$194,030
R21 · FY2024 · AG · contact PI
A new biomarker for frontotemporal lobar degeneration with TDP-43 proteinopathy and Alzheimer's disease$260,306
R21 · FY2023 · AG · contact PI